SMAD4 and pancreatic neoplasm: The results of these studies showed that the loss of SMAD4 in conjunction with KRASG12D stimulated the progression of pancreatic cancer development through various mechanisms, including accelerated fibrosis, enhanced acinar cell loss and accelerated development of various pre-invasive neoplastic lesions [75].